Russian Defense Ministry: Russian air defense forces shot down 13 Ukrainian drones in Kursk, Belgorod, Rostov and Lipetsk last night.Zhengrong Real Estate and others were forced to execute 230 million yuan. According to the information of legal proceedings, recently, Zhengrong Real Estate Holdings Co., Ltd. and Minhou Zhenghong Real Estate Development Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 230 million yuan. The enforcement court is Fuzhou Intermediate People's Court of Fujian Province.The Kuala Lumpur Composite Index of Malaysia closed up 0.4% at 1,608.75.
A picture to understand the 2024 Central Economic Work Conference. (Xinhua News Agency)Huang Hongfei, former CFO of McDonald's China, joined the company? Bawang Chaji: No response. Recently, it was reported in the market that Huang Hongfei, the former CFO of McDonald's China, recently left his post and joined Bawang Chaji after a short break. In response to this news, Bawang Chaji said that he would not respond. According to public information, Huang Hongfei joined McDonald's around 1995 and played an important role in the financial and strategic planning of McDonald's China. He was one of the key figures who witnessed the development of McDonald's China. (SSE)Yili shares: invested 130 million yuan to set up Anhui Jianwei Seed Fund. Yili shares announced that the company's wholly-owned limited partnerships, Jianwei Capital, Jianwei Seed Fund, Jianwei Parent Fund and Anhui Seed Fund jointly invested to set up Anhui Jianwei Seed Fund, with a total subscribed capital of 200 million yuan, and the company's wholly-owned limited partnerships contributed a total of 130 million yuan. The partnership term of the partnership enterprise is 12 years, and the fund can be extended twice for 1 year at the expiration of the term. The investment direction is mainly for the top ten emerging industries in Anhui Province, the future industries in the layout of new industries in various cities in the province and other key industries developed by the municipal government, focusing on small and medium-sized scientific and technological innovative enterprises with certain scientific and technological content and relatively new business models.
Huifa Food: Shareholder Zhenghechang Investment Co., Ltd.' s shareholding reduction plan has not been completed yet, and Huifa Food announced the change. On November 8, 2024, the company disclosed the Announcement of Huifa Food Shareholder's shareholding reduction plan, and Shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding to no more than 2,446,423 shares, which does not exceed 1% of the company's total share capital; The reduction of holdings through block trading does not exceed 4,892,846 shares, and does not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. As of December 13, 2024, shareholder Zhenghechang Investment Co., Ltd. has reduced its shareholding by 1.7 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.Institutions: The prospect of sanctions has caused supply concerns, and oil prices are bound to record an increase in Zhou Du and an increase in Zhou Du. The prospect of more severe sanctions on Russian and Iranian countries has caused market concerns about supply disruption. US Treasury Secretary Yellen said that the United States is looking for ways to curb Russia's income, and Trump's national security candidate vowed to put the greatest pressure on Iran. These two factors boosted the benchmark oil price by 3% to 4% this week. In addition, political turmoil in the Middle East and other factors have also provided support for oil prices. However, the International Energy Agency (IEA) said yesterday that the global market will still face oversupply next year.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
Strategy guide
12-14